Clinical Trial Update: throMboembolic Risk Associated To High atrIal Fibrillation riSk

View source ↗

Summary

A planned clinical study will evaluate thromboembolic and major adverse cardiovascular event risk in patients with high atrial fibrillation risk, incorporating …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Disease
• Cerebrovascular Disease

Snippet

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | Conditions: MACE, Atrial Fibrillation (AF) | Status: NOT_YET_RECRUITING